Skip to main content

Advertisement

SpringerLink
Log in

Smoking, smoking cessation, and risk of cardiovascular disease

  • Published:
Current Treatment Options in Cardiovascular Medicine Aims and scope Submit manuscript

Opinion statement

Cigarette smoking increases the risk of atherothrombotic clinical events such as myocardial infarction and the effect is dose dependent for persons who continue to smoke. Reductions in smoking habit and smoking cessation are important ways to improve cardiovascular risk and favorably affect primary and secondary prevention of clinical disease. Therapeutic methods to improve smoking reduction and cessation include nicotine replacement, behavioral interventions, and medications (bupropion, clonidine). Improved cessation rates are under active study and include behavioral methods, targeting smokers immediately after myocardial infarction, consideration of depression in smokers, pharmacogenomics to identify persons who may respond more favorably to specific interventions, and newer medications that affect endocannabinoid receptors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Pierce JP, Fiore MC, Novotny TE, et al: Trends in cigarette smoking in the United States. Projections to the year 2000. JAMA 1989, 261:61–65.

    Article  PubMed  CAS  Google Scholar 

  2. The worldwide smoking epidemic. Tobacco trade, use, and control. Council on Scientific Affairs [no authors listed]. JAMA 1990, 263:3312–3318.

    Article  Google Scholar 

  3. Doll R, Peto R: Mortality in relation to smoking: twenty years observation of male British doctors. BMJ 1976, 2:1525–1536.

    PubMed  CAS  Google Scholar 

  4. Cupples LA, D’Agostino RB: The Framingham Study. An Epidemiological Investigation of Cardiovascular Disease. Section 34: Some Risk Factors Related to the Annual Incidence of Cardiovascular Disease and Death Using Pooled Repeated Biennial Measurements: Framingham Heart Study, 30-year Follow-up, edn 1. Springfield, VA: US Department of Commerce; 1987.

    Google Scholar 

  5. Gyntelberg F, Lauridsen L, Beck Pedersen P, Schubell K: Smoking and risk of myocardial infarction in Copenhagen men aged 40–59 with special reference to cheroot smoking. Lancet 1981, 1:987–989.

    Article  PubMed  CAS  Google Scholar 

  6. Castelli WP, Garrison RJ, Dawber TR, et al: The filter cigarette and coronary heart disease: the Framingham Study. Lancet 1981, 2:109–113.

    Article  PubMed  CAS  Google Scholar 

  7. Palmer JR, Rosenberg L, Shapiro S: "Low yield" cigarettes and the risk of nonfatal myocardial infarction in women. N Engl J Med 1989, 320:1569–1573.

    Article  PubMed  CAS  Google Scholar 

  8. Doll R: Smoking and death rates. JAMA 1984, 251:2854–2857.

    Article  PubMed  CAS  Google Scholar 

  9. Herling S, Kozlowski LT: The importance of direct questions about inhalation and daily intake in the evaluation of pipe and cigar smokers. Prev Med 1988, 17:73–78.

    Article  PubMed  CAS  Google Scholar 

  10. Fielding JE, Phenow KJ: Health effects of involuntary smoking. N Engl J Med 1988, 319:1452–1460.

    Article  PubMed  CAS  Google Scholar 

  11. Beaglehole R: Does passive smoking cause heart disease? BMJ 1990, 301:1343–1344.

    PubMed  CAS  Google Scholar 

  12. McGill HC Jr: Potential mechanisms for the augmentation of atherosclerosis and atherosclerotic disease by cigarette smoking. Prev Med 1979, 8:390–403.

    Article  PubMed  CAS  Google Scholar 

  13. Craig WY, Palomaki GE, Haddow JE: Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ 1989, 298:784–788.

    PubMed  CAS  Google Scholar 

  14. Meade TW, Imeson J, Stirling Y: Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease. Lancet 1987, 2:986–988.

    Article  PubMed  CAS  Google Scholar 

  15. Jick H, Porter J, Morrison AS: Relation between smoking and age of natural menopause: report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center. Lancet 1977, 1:1354–1355.

    Article  PubMed  CAS  Google Scholar 

  16. Marti B, Abelin T, Minder CE, Vader JP: Smoking, alcohol consumption, and endurance capacity: an analysis of 6,500 19-year old conscripts and 4,100 joggers. Prev Med 1988, 17:79–92.

    Article  PubMed  CAS  Google Scholar 

  17. Khaw KT, Tazuke S, Barrett-Connor EL: Cigarette smoking and levels of adrenal androgens in postmenopausal women. N Engl J Med 1988, 318:1705–1709.

    Article  PubMed  CAS  Google Scholar 

  18. Barrett-Connor E, Khaw KT: Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study. Circulation 1988, 78:539–545.

    PubMed  CAS  Google Scholar 

  19. Rigotti NA: Cigarette smoking and body weight. N Engl J Med 1989, 320:931–933.

    Article  PubMed  CAS  Google Scholar 

  20. Kannel WB, D’Agostino RB, Belanger AJ: Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study. Am Heart J 1987, 113:1006–1010.

    Article  PubMed  CAS  Google Scholar 

  21. Keaney JF Jr, Larson MG, Vasan RS, et al: Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham study. Arterioscler Thromb Vasc Biol 2003, 23:434–439.

    Article  PubMed  CAS  Google Scholar 

  22. Visser M, Bouter LM, McQuillan GM, et al: Elevated Creactive protein levels in overweight and obese adults. JAMA 1999, 282:2131–2135.

    Article  PubMed  CAS  Google Scholar 

  23. Hecht SS, Murphy SE, Carmella SG, et al: Similar uptake of lung carcinogens by smokers of regular, light, and ultralight cigarettes. Cancer Epidemiol Biomarkers Prev 2005, 14:693–698.

    Article  PubMed  CAS  Google Scholar 

  24. Benowitz NL, Herrera B, Jacob P III: Mentholated cigarette smoking inhibits nicotine metabolism. J Pharmacol Exp Ther 2004, 310:1208–1215.

    Article  PubMed  CAS  Google Scholar 

  25. Huang S, Cook DG, Hinks LJ, et al: CYP2A6, MAOA, DBH, DRD4, and 5HT2A genotypes, smoking behaviour and cotinine levels in 1518 UK adolescents. Pharmacogenet Genomics 2005, 15:839–850.

    Article  PubMed  CAS  Google Scholar 

  26. Joseph AM, Bliss RL, Zhao F, Lando H: Predictors of smoking reduction without formal intervention. Nicotine Tob Res 2005, 7:277–282.

    Article  PubMed  Google Scholar 

  27. Hilleman DE, Mohiuddin SM, Packard KA: Comparison of conservative and aggressive smoking cessation treatment strategies following coronary artery bypass graft surgery. Chest 2004, 125:435–438.

    Article  PubMed  Google Scholar 

  28. Sivarajan Froelicher ES, Miller NH, Christopherson DJ, et al: High rates of sustained smoking cessation in women hospitalized with cardiovascular disease: the Women’s Initiative for Nonsmoking (WINS). Circulation 2004, 109:587–593.

    Article  Google Scholar 

  29. Croghan IT, Schroeder DR, Hays JT, et al: Nicotine dependence treatment: perceived health status improvement with 1-year continuous smoking abstinence. Eur J Public Health 2005, 15:251–255.

    Article  PubMed  Google Scholar 

  30. Ockene JK, Kuller LH, Svendsen KH, Meilahn E: The relationship of smoking cessation to coronary heart disease and lung cancer in the Multiple Risk Factor Intervention Trial (MRFIT). Am J Public Health 1990, 80:954–958.

    Article  PubMed  CAS  Google Scholar 

  31. Jajich CL, Ostfeld AM, Freeman DH: Smoking and coronary heart disease mortality in the elderly. JAMA 1984, 252:2831–2834.

    Article  PubMed  CAS  Google Scholar 

  32. LaCroix AZ, Lang J, Scherr P, et al: Smoking and mortality among older men and women in three communities. N Engl J Med 1991, 324:1619–1625.

    Article  PubMed  CAS  Google Scholar 

  33. An LC, Zhu SH, Nelson DB, et al: Benefits of telephone care over primary care for smoking cessation: a randomized trial. Arch Intern Med 2006, 166:536–542.

    Article  PubMed  Google Scholar 

  34. Fu SS, Sherman SE, Yano EM, et al: Ethnic disparities in the use of nicotine replacement therapy for smoking cessation in an equal access health care system. Am J Health Promot 2005, 20:108–116.

    PubMed  Google Scholar 

  35. Frishman WH, Mitta W, Kupersmith A, Ky T: Nicotine and non-nicotine smoking cessation pharmacotherapies. Cardiol Rev 2006, 14:57–73. Comprehensive review of the current pharmacotherapies and propects for newer agents to reduce smoking.

    Article  PubMed  Google Scholar 

  36. Perkins KA, Doyle T, Ciccocioppo M, et al: Sex differences in the influence of nicotine dose instructions on the reinforcing and self-reported rewarding effects of smoking. Psychopharmacology (Berl) 2006, 184:600–607.

    Article  CAS  Google Scholar 

  37. Tonstad S, Johnston JA: Does bupropion have advantages over other medical therapies in the cessation of smoking? Expert Opin Pharmacother 2004, 5:727–734.

    Article  PubMed  CAS  Google Scholar 

  38. Gourlay SG, Stead LF, Benowitz NL: Clonidine for smoking cessation. Cochrane Database Syst Rev 2004, (3):CD000058.

    PubMed  Google Scholar 

  39. Tonstad S: Rimonabant: a cannabinoid receptor blocker for the treatment of metabolic and cardiovascular risk factors. Nutr Metab Cardiovasc Dis 2006, 16:156–162.

    Article  PubMed  CAS  Google Scholar 

  40. Ludvig J, Miner B, Eisenberg MJ: Smoking cessation in patients with coronary artery disease. Am Heart J 2005, 149:565–572. Review and summary analyses of the effects of various interventions to reduce smoking.

    Article  PubMed  Google Scholar 

  41. Hjermann I, Holme I, Leren P: Oslo Study Diet and Antismoking Trial. Results after 102 months. Am J Med 1986, 80(suppl 2A):7–11.

    Article  PubMed  CAS  Google Scholar 

  42. Vlietstra RE, Kronmal RA, Oberman A, et al: Effect of cigarette smoking on survival of patients with angiographically documented coronary artery disease: report from the CASS registry. JAMA 1986, 255:1023–1027.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical University South Carolina, 96 Jonathan Lucas Street, Suite 815, 29425, Charleston, SC, USA

    Peter W. F. Wilson MD

Authors
  1. Peter W. F. Wilson MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wilson, P.W.F. Smoking, smoking cessation, and risk of cardiovascular disease. Curr Treat Options Cardio Med 8, 276–281 (2006). https://doi.org/10.1007/s11936-006-0048-0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11936-006-0048-0

Keywords

Search

Navigation